The Berlin Institute of Health at Charité (BIH) successfully concluded its Digital Health Accelerator Demo Day in October 2025. The virtual event brought together clinicians, researchers, investors, and innovators in digital health to present solutions developed by those working closest to patients.…
The Coalition for Advancing Research Assessment (CoARA) is awarding the Berlin Institute of Health at Charité nearly €60,000 to advance the development of a transparent and fair infrastructure for evaluating research groups. To this end, BIH researchers are expanding the existing MERIT portal for…
On October 9, 2025, around 400 members of the Berlin Institute of Health at Charité (BIH) came together from across the different campuses for a day dedicated to exchange, collaboration, and networking. The symposium focused entirely on translation – it served as the guiding theme and unifying…
SPARK-BIH celebrated its 10th anniversary this fall with a three-day series of events at the historic Villa Elisabeth in Berlin. The occasion brought together more than 220 participants — including colleagues, founders, supporters, advisors, alumni, and current SPARK teams — to reflect on a decade…
The Berlin Institute of Health at Charité (BIH) bids farewell to Prof. Dr. Ulrich Dirnagl, honoring him as a central driving force for trustworthy and useful research upon his retirement. The internationally recognized stroke researcher and advocate of responsible science has shaped the biomedical…
Over 130 researchers and change-makers gathered from 22 to 24 September in Berlin for RRiA Unconference 2025, a three-day event driving transformation in research culture. With inspiring talks, hands-on projects, and vibrant networking, participants united to rethink and improve how science is done…
The Berlin Institute of Health at Charité (BIH) is strengthening its expertise in translational research with two new W2 professorships: Dr. Sven Geißler has been appointed Professor of “Biological Foundations of Musculoskeletal Regeneration,” and Dr. Daniel Ibrahim has been appointed Professor of…
In a study published at the end of August in the journal Molecular Therapy, Michael Kaminski, Verena Klämbt, and Matteus Krappitz – all participants of the BIH Charité Clinician Scientist Program – report an advancement in the fight against autosomal dominant polycystic kidney disease (ADPKD). The…
A person's metabolism is as unique as their fingerprint, and so is their risk of developing certain diseases. A better understanding of the genetic influences on metabolism could open up new therapeutic options. Researchers at the Berlin Institute of Health at Charité (BIH) and Queen Mary University…
